Henrik Johan Wingstrand
Directeur Général chez T-Bolaget AB
Profil
Henrik Johan Wingstrand is currently the Chief Executive Officer & Director at T-Bolaget AB since 2014.
Prior to this, he held positions as Director at Takara Bio Europe AB, Denator AB, and SentoClone AB.
Postes actifs de Henrik Johan Wingstrand
| Sociétés | Poste | Début |
|---|---|---|
T-Bolaget AB
 T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Directeur Général | - |
Anciens postes connus de Henrik Johan Wingstrand
| Sociétés | Poste | Fin |
|---|---|---|
SentoClone AB
 SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Directeur/Membre du Conseil | 31/12/2012 |
Denator AB
 Denator AB Medical SpecialtiesHealth Technology Denator AB provides instruments and consumables that stabilize biological samples. It develops, markets and sells instruments and consumables to address needs in the life science and clinical research markets. The firm's products enable scientists to stabilize biological samples, such as tissue sections or cellular biopsies, from the moment of sampling. The company was founded by Olof Sköld and Karl Sköld in 2004 and is headquartered in Göteborg, Sweden. | Directeur/Membre du Conseil | - |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
Denator AB
Denator AB Medical SpecialtiesHealth Technology Denator AB provides instruments and consumables that stabilize biological samples. It develops, markets and sells instruments and consumables to address needs in the life science and clinical research markets. The firm's products enable scientists to stabilize biological samples, such as tissue sections or cellular biopsies, from the moment of sampling. The company was founded by Olof Sköld and Karl Sköld in 2004 and is headquartered in Göteborg, Sweden. | Health Technology |
T-Bolaget AB
T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Finance |
